NMPA Approval

Haemophilus Influenzae Type b Conjugate Vaccine

Approval Number

S20140013

Registration Date

April 12, 2020

Previous Approval Numbers

S20140013

Drug Information

Generic Name

b型流感嗜血杆菌结合疫苗

Trade Name

安尔宝

Dosage Form

注射剂

Strength

10μg/支(含预充型注射器装稀释液0.5ml/支)

Drug Type

生物制品

Registration Date

April 12, 2020

Expiry Date

April 11, 2025

Company Address

14 Espace Henry Vallee 69007 LYON，France

Company Address

1541 avenue Marcel Merieux，69280 MARCY L'ETOILE，France

Empowering clinical research with data-driven insights and AI-powered tools.

b型流感嗜血杆菌结合疫苗 - NMPA 批准文号 | MedPath